News
NIH inventors have developed a mutation-independent method to treat Leber congenital amaurosis (LCA), retinitis pigmentosa (RP), other inherited retinal degenerations (IRDs), and age-related macular degeneration (AMD) using the FDA-approved small molecule, Halofantrine. NIH inventors found
Join the Federal Laboratory Consortium for an informational webinar on how to license technologies from the NIH. The U.S. government invests heavily into healthcare research and development through the NIH but needs commercial partners in order to develop these products and bring them to market
NIH is seeking a licensee or collaborator for Nipamovir, an affordable oral treatment for HIV infection with a high barrier to resistance. Nipamovir is a low molecular weight mercaptobenzamide derivative that is simple to produce and can be used to lower or eliminate the infectivity of HIV. It
NIH inventors are seeking a licensee or collaborator for a micro-engineered “thyroid-on-a-chip” that combines human thyroid organoids with integrated micro-vasculature to replicate the gland’s native blood flow and 3-D architecture, enabling rapid, patient-specific drug screening. This technology